慢性盆腔炎的中医药内治近况

【作者】 姚奏英；

【导师】 陆华；

【作者基本信息】 成都中医药大学 ， 中医妇科学， 2005， 硕士

【副题名】花红片、妇科千金片治疗慢性盆腔炎湿热瘀结证180例三中心临床观察

【摘要】 目的:综述慢性盆腔炎中医药内治近况:观察花红片与妇科千金片治疗慢性盆腔炎(湿热瘀结证)的临床疗效。 方法:综述慢性盆腔炎的流行病学、病因病机、辨证治疗、辨病治疗与中成药治疗近况;观察花红片与妇科千金片治疗慢性盆腔炎(湿热瘀结证)共180例临床疗效。治疗方法:花红片5片/次,每日3次;妇科千金片6片/次,每日3次。治疗疗程21天,观察患者治疗前后临床症状、体征等的变化。 结果:根据所收集的130篇文献的报道,慢性盆腔炎临床分湿热瘀结、气虚湿瘀、痰湿瘀结、肾虚血瘀等10种证型,其中湿热瘀结证最常见,清热利湿、活血化瘀法应用最为广泛;常用的上市中成药有花红片、妇科千金片、妇乐颗粒、金鸡片、金刚藤糖浆等19种,其中有16种为针对湿热瘀结证型者。临床观察结果:花红片组90例,治愈2例(2.22%),显效35例(38.89%),有效46例(51.11%),无效7例(7.77%),总愈显率为41.11%,总有效率为92.22%;妇科千金片组90例,治愈0例,显效18例(20.00%),有效60例(66.67%),无效13例(14.44%),总愈显率为20.00%,总有效率为85.56%;两组总有效率比较无显著性差异(P>0.05),对中医证候、局部体征均有显著改善(P<0.05)。 结论: 1.湿热瘀阻是本病的主要病机,湿热瘀结证是最常见的证型,清热利湿、活血化瘀是本病的基本治法。 2.辨病与辨证相结合是本病中医内治的基本方法。 3.花红片及妇科千金片均为治疗慢性盆腔炎(湿热瘀阻证)的有效中成药,花红片更适宜于慢性盆腔炎湿热瘀阻而偏重于实证者,妇科千金片适宜于湿热瘀阻兼气虚而偏重于虚证者。更多还原

【Abstract】 Objective: To summarize the development of internal treatment of Chronic pelvic inflammatory disease(Chronic PID) ;To observe the clinical curative effect of Huahong tablets and Fukeqianjin tablets,which are used to treat dampness-heat combinning with blood stasis syndrome of Chronic PID.Method: To overview the general situation of the epidemiology, pathogenic facts,pathogenesis, correlative research of mechanism and efficiency of Chinese patent medicines of Chronic PID. We collected 180 cases of Chronic PID in 3 centres. Usage:Huahong tablets,5 tablets ,Tid; Fukeqianjin tablets,6 tablets,Tid. After 21 days as one period of treatment , comparing the differentiations of symptoms and physical signs with treating before.Result: There are about 10 types of syndromes of Chronic PID. Mostly Chinese patent medicines of Chronic PID aimed at dampness-heat combinning with blood stasis syndrome . As a clinical result, the total cure and prominent efficiency ratio of Huahong tablets group is 41.11%,the total efficiency ratio is 92.22% ; the total cure and prominent efficiency ratio of Fukeqianjin tablets group is 20.00%,the total efficiency ratio is 85.56%.Both Huahong tablets and Fukeqianjin tablets can improve the patients’s symptoms and physical signs prominently (P<0.05) .Conclusion: The pathogenesis of CPID is complicated, the fundamental syndrome is dampness-heat combinning with blood stasis syndrome . Nowadays treatment which bases on the combination of disease identification and syndrome differentiation is the basic means of internal treatment. The two kinds of Chinese patent medicines are both effective for the fundamental syndrome. Huahong tablets lays particular stress on excess syndrome,while Fukeqianjin tablets lays particular stress on qi-deficiency syndrome.更多还原